Roche Holding AG
RO
Peringkat dalam Saham
#43
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Harga Saham
$514.50
Kapitalisasi Pasar
$349.98B
Perubahan (1 hari)
2.59%
Perubahan (1 tahun)
38.12%
Negara
CH
Perdagangan Roche Holding AG (RO)
Kategori
Healthcare
Laba untuk Roche Holding AG (RO)
Laba pada Dec 2025 TTM: $21.39B
Menurut laporan keuangan terbaru dari Roche Holding AG, laba saat ini perusahaan adalah $21.39B. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Roche Holding AG dari 2026 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $33.60B | 57.07% |
US
|
|
| $17.74B | -17.07% |
US
|
|
| $8.70B | -59.33% |
US
|
|
| $5.95B | -72.19% |
US
|
|
| $16.38B | -23.42% |
CH
|
